AIIMS planning to conduct clinical trial of plasma therapy

AIIMS Director Dr Randeep Guleria said the mode of treatment in COVID-19 is still at an "experimental stage" and there is a need for good and well conducted research trials before its benefit and this mode of therapy can be recommended for routine use in coronavirus patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2VLabwl
via IFTTT